Cardiology Research, ISSN 1923-2829 print, 1923-2837 online, Open Access |
Article copyright, the authors; Journal compilation copyright, Cardiol Res and Elmer Press Inc |
Journal website https://www.cardiologyres.org |
Original Article
Volume 14, Number 3, June 2023, pages 211-220
A Prospective, Randomized Open-Label Study for Assessment of Antihypertensive Effect of Telmisartan Versus Cilnidipine Using Ambulatory Blood Pressure Monitoring (START ABPM Study)
Figures
Tables
Characteristics | Group | P value | |
---|---|---|---|
Telmisartan (n = 17) | Cilnidipine (n = 19) | ||
Data are mean (SD), and 95% CI for mean for continuous variables, and number (%) for categorical variables. Percentages are based on the final analysis sample of the respective group. The P value for continuous variable is according to t-test for independent sample, while for categorical variable is using Pearson’s Chi-square test. CI: confidence interval; BMI: body mass index; BP: blood pressure; SD: standard deviation. | |||
Age in years | 41.88 (11.16); 36.15, 47.62 | 41.47 (12.69); 35.36, 47.59 | 0.651 |
Gender | |||
Female | 7 (41.2) | 11 (57.9) | 0.317 |
Male | 10 (58.8) | 8 (42.1) | |
Height (cm) | 166.44 (6.79); 162.94, 169.93 | 165.15 (8.02); 161.29, 169.02 | 0.608 |
Weight (kg) | 74.15 (12.91); 67.51, 80.78 | 70.32 (12.63); 64.24, 76.41 | 0.375 |
BMI (kg/m2) | 26.84 (5.15); 24.19, 29.49 | 25.78 (4.41); 23.65, 27.90 | 0.510 |
BP systolic (mm Hg) | 154.53 (8.45); 150.45, 158.6 | 155.24(8.72); 151.27, 159.21 | 0.795 |
BP diastolic (mm Hg) | 99.63 (6.61); 96.45, 102.82 | 102.38(10.17); 97.75, 107.01 | 0.323 |
Pulse rate (/min) | 90.42 (9.14); 86.02, 94.82 | 88.76 (10.8); 83.84, 93.68 | 0.605 |
Respiratory rate (/min) | 19.79 (1.72); 18.96, 20.62 | 19.71 (1.19); 19.17, 20.26 | 0.872 |
Temperature (°F) | 97.28 (0.69); 96.95, 97.62 | 97.23 (0.78); 96.88, 97.58 | 0.812 |
ABPM-derived variables (mm Hg) | Telmisartan (n = 17) | Cilnidipine (n = 19) | P valueb | ||||||
---|---|---|---|---|---|---|---|---|---|
Baseline | Day 56 | P valuea | Change: Baseline to day 56 | Baseline | Day 56 | P valuea | Change: Baseline to day 56 | ||
Data are mean (SD), and 95% CI for mean. aObtained using paired t-test. bObtained using t-test for independent samples. P values < 0.05 indicate statistical significance. Change in BP is calculated as baseline - day 56. CI: confidence interval; BP: blood pressure; SD: standard deviation; ABPM: ambulatory blood pressure monitoring. | |||||||||
Systolic, 24 h | 142.47 (10.55) | 128.47 (11.61) | 0.002 | -14.00 (15.88) | 140.44 (11.24) | 132.83 (13.86) | 0.007 | -7.61 (10.51) | 0.174 |
126, 166 | 116, 156 | -22.17, -5.83 | 123, 170 | 107, 174 | -12.57, -2.65 | ||||
Diastolic, 24 h | 91.18 (6.97) | 82.91 (7.51) | 0.012 | -8.26 (12.03) | 88.39 (10.4) | 84.8 (9.21) | 0.087 | -3.59 (8.41) | 0.196 |
81.4, 102 | 74.6, 101 | -14.45, -2.08 | 65.2, 113 | 65.9, 109 | -7.55, 0.37 | ||||
Systolic, last 6 h | 145.65 (13.09) | 128.88 (12.41) | < 0.001 | -16.77 (14.72) | 139.48 (11.83) | 135.2 (12.46) | 0.148 | -4.28 (12.01) | 0.010 |
125, 173.3 | 112.9, 165 | -24.34, -9.2 | 117.8, 164.3 | 112.5, 162.3 | -9.94, 1.37 | ||||
Diastolic, last 6 h | 94.69 (10.05) | 83.92 (8.35) | 0.002 | -10.76 (12.26) | 87.79 (10.31) | 86.53 (7.89) | 0.521 | -1.26 (8.15) | 0.014 |
77, 110.7 | 73.1, 111.3 | -17.07, -4.46 | 69.6, 109.5 | 70.7, 101.6 | -5.1, 2.58 | ||||
Systolic, morning | 146.18 (13.08) | 129.84 (11.54) | < 0.001 | -16.34 (12.84) | 141.95 (11.09) | 136.21 (12.27) | 0.058 | -5.74 (12.07) | 0.019 |
125.8, 170.3 | 114.5, 161.7 | -22.94, -9.74 | 126.3, 164.3 | 114.4, 161.8 | -11.43, -0.04 | ||||
Diastolic, morning | 94.66 (10.41) | 84.82 (7.55) | 0.002 | -9.85 (10.95) | 89.46 (9.93) | 87.35 (7.56) | 0.321 | -2.11 (8.47) | 0.028 |
77.4, 112.4 | 74.7, 109.1 | -15.48, -4.22 | 70, 109.5 | 72.3, 101.7 | -6.09, 1.88 | ||||
Systolic, daytime | 145.12 (10.89) | 130.86 (11.35) | 0.001 | -14.26 (13.62) | 144 (10.92) | 136.95 (15.84) | 0.011 | -7.05 (10.62) | 0.092 |
129.1, 162.9 | 117.1, 155.7 | -21.26, -7.25 | 129.5, 175.5 | 110.2, 188.1 | -12.06, -2.04 | ||||
Diastolic, daytime | 93.58 (8.01) | 84.75 (7.29) | 0.004 | -8.84 (10.67) | 90.78 (10.82) | 87.41 (10.31) | 0.126 | -3.37 (8.89) | 0.111 |
81.8, 105.1 | 75.5, 103.3 | -14.32, -3.35 | 65.3, 116.7 | 67.2, 117.5 | -7.56, 0.82 | ||||
Systolic, night | 137.95 (16.64) | 121.85 (14.81) | 0.011 | -16.09 (23.17) | 134.22 (14.37) | 125.46 (12.62) | 0.028 | -8.76 (15.5) | 0.263 |
115.6, 178.5 | 106, 158.8 | -28.01, -4.18 | 110.6, 166.1 | 100.1, 155.7 | -16.06, -1.45 | ||||
Diastolic, night | 85.74 (8.29) | 74.68 (7.05) | 0.004 | -11.07 (12.8) | 82.26 (11.27) | 77.69 (8.03) | 0.101 | -4.57 (11.53) | 0.128 |
72.8, 105.9 | 66.4, 96.5 | -17.47, -4.67 | 59.9, 100.7 | 61.8, 90.7 | -10.12, 0.99 | ||||
Systolic, manual | 155.18 (8.50) | 137.07 (7.96) | < 0.001 | -18.19 (11.97) | 154.21 (8.22) | 139.95 (9.49) | < 0.001 | -14.26 (12.01) | 0.104 |
144, 166 | 123, 152 | -24.56, -11.81 | 141, 170 | 119, 154 | -20.05, -8.48 | ||||
Diastolic, manual | 98.63 (6.52) | 87.00 (7.26) | < 0.001 | -11.63 (9.42) | 101.37 (10.45) | 85.63 (7.68) | < 0.001 | -15.74 (14.32) | 0.367 |
87, 111 | 76, 101 | -16.86, -7.13 | 77, 120 | 72, 97 | -22.64, -8.83 |
Nocturnal dip (%) | Group | P valueb | |||||||
---|---|---|---|---|---|---|---|---|---|
Telmisartan (n = 17) | Cilnidipine (n = 19) | ||||||||
Baseline | Day 56 | Change: baseline to day 56 | P valuea | Baseline | Day 56 | Change: baseline to day 56 | P valuea | ||
Data are mean (SD); and 95% CI for mean. aObtained using paired t-test. bObtained using t-test for independent samples. Change in nocturnal dip is calculated as day 56 - baseline. CI: confidence interval; BP: blood pressure; SD: standard deviation | |||||||||
Systolic BP | 4.93 (8.65); 0.48, 9.37 | 7.07 (4.45); 4.78, 9.36 | 2.14 (10.34); -3.17, 7.46 | 0.405 | 6.45 (6.4); 3.36, 9.53 | 7.69 (4.25); 5.64, 9.74 | 1.25 (8.00); -2.61, 5.11 | 0.505 | 0.771 |
Diastolic BP | 9.05 (8.23); 4.82, 13.28 | 10.04 (5.38); 7.27, 12.81 | 0.99 (10.88); -4.60, 6.58 | 0.712 | 10.17 (7.42); 6.59, 13.74 | 10.21 (5.5); 7.56, 12.86 | 0.04 (10.01); -4.79, 4.87 | 0.986 | 0.787 |
Smoothness index | Parameter | All patients | ||
---|---|---|---|---|
Group | P valuea | |||
Telmisartan (n = 17) | Cilnidipine (n = 19) | |||
aObtained using t-test for independent samples. SD: standard deviation; BP: blood pressure; IQR: interquartile range. | ||||
Systolic BP | Mean | 1.79 | 1.38 | 0.601 |
SD | 1.52 | 2.82 | ||
Median | 2.3 | 0.75 | ||
IQR | 1.55 | 1.31 | ||
Diastolic BP | Mean | 1.44 | 0.68 | 0.167 |
SD | 1.6 | 1.54 | ||
Median | 1.62 | 0.68 | ||
IQR | 2.66 | 2.2 |